Francesco Rubino is Professor of Metabolic and Bariatric Surgery at King’s College London and a consultant surgeon at King’s College Hospital (KCH). Prof. Rubino’s studies in rodents provided the first experimental evidence of weight-independent effects of GI surgery on glucose metabolism and the specific anti-diabetic effects of the exclusion of the duodenum from nutrient transit. These findings offered a biological rationale for re-purposing gastrointestinal and bariatric operations as a treatment for type 2 diabetes - a surgical discipline now referred to as “Metabolic Surgery”. Dr Rubino was the main organizer and co-director of the Diabetes Surgery Summit, a series of consensus conference that developed global clinical guidelines for surgical treatment of diabetes. He recently led the joint international consensus statement (Nature Medicine, March 2020) and “Pledge to eradicate Obesity Stigma” now endorsed by over 500 organizations, institutions, scientific journals, industries and individual scientists/clinicians. Francesco Rubino received his MD and completed his residency in general surgery at the Catholic University/Policlinico Gemelli in Rome, Italy. He completed fellowships in minimally invasive surgery at the European Institute of Telesurgery in Strasbourg, France, Mount Sinai Medical Center in New York and at the Cleveland Clinic in Cleveland, Ohio. Before joining King’s he was Chief of Gastrointestinal Metabolic Surgery and Director of the Diabetes Surgery Center at Weill Cornell Medical College and New York Presbyterian Hospital in New York, USA.